AI Might Spot At-Risk COVID-19 Patients

Coronavirus

Developed by U.S. and Chinese researchers, the artificial intelligence (AI) program has been tested at two hospitals in China with 53 patients who were diagnosed in January with COVID-19. The new tool is considered experimental and is now in testing.

Written by Newport Beach Compounding Center Staff

As one of the most experienced compounding pharmacies in Newport Beach, We provide a valuable service working together with physicians and patients to create medications tailored to specific requirements. We are specialists in the art and science of pharmacy compounding. Our Team of experts can meet all of your unique pharmaceutical needs.

No Comments Yet.

Leave a Reply

You must be logged in to post a comment.